X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (579) 579
Publication (21) 21
Book Review (9) 9
Newsletter (3) 3
Newspaper Article (3) 3
Magazine Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (404) 404
solifenacin succinate (339) 339
index medicus (285) 285
urinary bladder, overactive - drug therapy (256) 256
male (252) 252
solifenacin (250) 250
overactive bladder (244) 244
female (234) 234
middle aged (209) 209
urology & nephrology (202) 202
muscarinic antagonists - therapeutic use (198) 198
aged (182) 182
treatment outcome (172) 172
quinuclidines - therapeutic use (159) 159
tetrahydroisoquinolines - therapeutic use (158) 158
urinary incontinence (158) 158
tolterodine (127) 127
adult (125) 125
efficacy (104) 104
muscarinic antagonists - adverse effects (102) 102
muscarinic antagonists - administration & dosage (97) 97
quality of life (92) 92
pharmacology & pharmacy (91) 91
aged, 80 and over (90) 90
double-blind (88) 88
quality-of-life (88) 88
quinuclidines - adverse effects (88) 88
tetrahydroisoquinolines - adverse effects (88) 88
antimuscarinic agent solifenacin (86) 86
urology (77) 77
double-blind method (76) 76
solifenacin succinate - therapeutic use (76) 76
quinuclidines - administration & dosage (73) 73
tetrahydroisoquinolines - administration & dosage (73) 73
oxybutynin (68) 68
prospective studies (68) 68
care and treatment (67) 67
urinary incontinence - drug therapy (67) 67
tolterodine tartrate (64) 64
drug therapy, combination (63) 63
incontinence (63) 63
symptoms (58) 58
urinary bladder, overactive - physiopathology (56) 56
bladder (55) 55
analysis (53) 53
animals (53) 53
drug therapy (53) 53
medicine & public health (53) 53
urinary-incontinence (53) 53
urinary-tract symptoms (53) 53
tolerability (52) 52
urological agents - therapeutic use (52) 52
controlled trial (51) 51
solifenacin succinate - administration & dosage (47) 47
benzhydryl compounds - therapeutic use (46) 46
medicine, general & internal (46) 46
safety (46) 46
urinary bladder (46) 46
therapy (44) 44
urgency (44) 44
women (44) 44
clinical trials (43) 43
dose-response relationship, drug (43) 43
muscarinic antagonists - pharmacology (43) 43
quinuclidines - pharmacology (41) 41
placebo-controlled trial (40) 40
randomized controlled trials as topic (40) 40
urinary bladder - drug effects (39) 39
detrusor overactivity (38) 38
tetrahydroisoquinolines - pharmacology (38) 38
benign prostatic hyperplasia (37) 37
cresols - therapeutic use (37) 37
phenylpropanolamine - therapeutic use (37) 37
obstetrics & gynecology (36) 36
trospium chloride (36) 36
urinary bladder, overactive - complications (36) 36
urological agents - administration & dosage (36) 36
validation (35) 35
men (34) 34
overactive bladder syndrome (34) 34
urological agents - adverse effects (34) 34
surveys and questionnaires (33) 33
urinary-bladder (33) 33
adolescent (32) 32
antimuscarinics (32) 32
tamsulosin (32) 32
urinary bladder, overactive - diagnosis (32) 32
young adult (32) 32
mirabegron (31) 31
urodynamics - drug effects (31) 31
antimuscarinic (30) 30
darifenacin (30) 30
lower urinary tract symptoms - drug therapy (30) 30
succinate (30) 30
urinary bladder, overactive (30) 30
pharmacokinetics (29) 29
rats (29) 29
severity of illness index (29) 29
solifenacin succinate - adverse effects (29) 29
time factors (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (540) 540
Japanese (17) 17
Russian (15) 15
German (12) 12
Chinese (5) 5
French (3) 3
Spanish (3) 3
Bulgarian (2) 2
Italian (2) 2
Korean (2) 2
Polish (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Parkinsonism and Related Disorders, ISSN 1353-8020, 2015, Volume 21, Issue 5, pp. 514 - 520
Abstract Objective To evaluate the efficacy of solifenacin succinate in Parkinson's disease (PD) patients suffering from overactive bladder (OAB). Background... 
Neurology | Urinary incontinence | Overactive bladder | Non-motor symptoms | Parkinson's disease | Solifenacin succinate | METAANALYSIS | VOIDING DYSFUNCTION | MECHANISMS | PREVALENCE | CLINICAL NEUROLOGY | PERCEPTION | NONMOTOR SYMPTOMS | URINARY SYMPTOMS | UPDATE | QUALITY-OF-LIFE | QUESTIONNAIRE
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 06/2019, Volume 565, pp. 325 - 332
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 05/2004, Volume 492, Issue 2-3, pp. 243 - 250
Journal Article
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2007, Volume 30, Issue 1, pp. 54 - 58
Solifenacin succinate [YM905; (3R)-1-azabicyclo[2.2.2]oct-3-yl(1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate monosuccinate] is a new muscarinic... 
bladder capacity | solifenacin | urinary bladder | muscarinic receptor | Muscarinic receptor | Solifenacin | Urinary bladder | Bladder capacity | OVERACTIVE BLADDER SYNDROME | M-3 MUSCARINIC RECEPTORS | RAT | URINARY-BLADDER | DETRUSOR OVERACTIVITY | TOLTERODINE | SALIVARY-GLAND | IN-VITRO | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | MICE | Cricetulus | Rats, Wistar | Solifenacin Succinate | Benzofurans - pharmacology | Male | Phenylpropanolamine - pharmacology | Receptors, Muscarinic - metabolism | Muscarinic Antagonists - therapeutic use | Pyrrolidines - pharmacology | Dose-Response Relationship, Drug | Mandelic Acids - pharmacology | Muscle, Smooth - drug effects | Urinary Bladder, Overactive - drug therapy | Quinuclidines - therapeutic use | Receptors, Muscarinic - drug effects | Transfection | Muscarinic Antagonists - pharmacology | Tolterodine Tartrate | Urination - drug effects | Benzilates - pharmacology | Cholinergic Agonists - pharmacology | Cresols - pharmacology | CHO Cells | Muscarinic Antagonists - metabolism | Binding, Competitive | Tetrahydroisoquinolines - pharmacology | Cricetinae | Quinuclidines - pharmacology | Rats | Atropine - pharmacology | Tetrahydroisoquinolines - therapeutic use | Rats, Sprague-Dawley | Carbachol - pharmacology | Animals | Muscle Contraction - drug effects | Tetrahydroisoquinolines - metabolism | N-Methylscopolamine - metabolism | Urinary Bladder - drug effects | Benzhydryl Compounds - pharmacology | In Vitro Techniques | Quinuclidines - metabolism
Journal Article
Journal Article
Journal Article